These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Studies on the antigens of invasive stages of Plasmodium yoelii and Plasmodium berghei]. Jin LQ; Luo JM; Fu YC; Xu SE; Guo Y; Xie LC; Tsuboi T; Torii M Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2003; 21(5):272-4. PubMed ID: 15108514 [TBL] [Abstract][Full Text] [Related]
26. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge. Rotman HL; Daly TM; Long CA Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045 [TBL] [Abstract][Full Text] [Related]
27. Infection with Plasmodium berghei boosts antibody responses primed by a DNA vaccine encoding gametocyte antigen Pbs48/45. Haddad D; Maciel J; Kumar N Infect Immun; 2006 Apr; 74(4):2043-51. PubMed ID: 16552033 [TBL] [Abstract][Full Text] [Related]
28. Plasmodium berghei XAT: contribution of gammadelta T cells to host defense against infection with blood-stage nonlethal malaria parasite. Kobayashi F; Niikura M; Waki S; Matsui T; Fujino T; Tsuruhara T; Kamiya S Exp Parasitol; 2007 Dec; 117(4):368-75. PubMed ID: 17601562 [TBL] [Abstract][Full Text] [Related]
29. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge. Sauzet JP; Perlaza BL; Brahimi K; Daubersies P; Druilhe P Infect Immun; 2001 Feb; 69(2):1202-6. PubMed ID: 11160023 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of immunogenicity of an oral Salmonella vaccine expressing recombinant Plasmodium berghei merozoite surface protein-1. Toebe CS; Clements JD; Cardenas L; Jennings GJ; Wiser MF Am J Trop Med Hyg; 1997 Feb; 56(2):192-9. PubMed ID: 9080880 [TBL] [Abstract][Full Text] [Related]
31. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine. Wang R; Charoenvit Y; Corradin G; Porrozzi R; Hunter RL; Glenn G; Alving CR; Church P; Hoffman SL J Immunol; 1995 Mar; 154(6):2784-93. PubMed ID: 7876549 [TBL] [Abstract][Full Text] [Related]
32. Recombinant pseudorabies virus carrying a plasmodium gene: herpesvirus as a new live viral vector for inducing T- and B-cell immunity. Sedegah M; Chiang CH; Weiss WR; Mellouk S; Cochran MD; Houghten RA; Beaudoin RL; Smith D; Hoffman SL Vaccine; 1992; 10(9):578-84. PubMed ID: 1323900 [TBL] [Abstract][Full Text] [Related]
33. Suppression of lethal Plasmodium yoelii malaria following protective immunization requires antibody-, IL-4-, and IFN-gamma-dependent responses induced by vaccination and/or challenge infection. Petritus PM; Burns JM J Immunol; 2008 Jan; 180(1):444-53. PubMed ID: 18097046 [TBL] [Abstract][Full Text] [Related]
34. Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Khusmith S; Charoenvit Y; Kumar S; Sedegah M; Beaudoin RL; Hoffman SL Science; 1991 May; 252(5006):715-8. PubMed ID: 1827210 [TBL] [Abstract][Full Text] [Related]
35. Isolation of merozoite rhoptries, identification of novel rhoptry-associated proteins from Plasmodium yoelii, P. chabaudi, P. berghei, and conserved interspecies reactivity of organelles and proteins with P. falciparum rhoptry-specific antibodies. Sam-Yellowe TY; Del Rio RA; Fujioka H; Aikawa M; Yang JC; Yakubu Z Exp Parasitol; 1998 Jul; 89(3):271-84. PubMed ID: 9676705 [TBL] [Abstract][Full Text] [Related]
36. A small peptide (CEL-1000) derived from the beta-chain of the human major histocompatibility complex class II molecule induces complete protection against malaria in an antigen-independent manner. Charoenvit Y; Brice GT; Bacon D; Majam V; Williams J; Abot E; Ganeshan H; Sedegah M; Doolan DL; Carucci DJ; Zimmerman DH Antimicrob Agents Chemother; 2004 Jul; 48(7):2455-63. PubMed ID: 15215094 [TBL] [Abstract][Full Text] [Related]
37. Plasmodium yoelii blood-stage antigens newly identified by immunoaffinity using purified IgG antibodies from malaria-resistant mice. Kamali AN; Marín-García P; Azcárate IG; Diez A; Puyet A; Bautista JM Immunobiology; 2012 Aug; 217(8):823-30. PubMed ID: 22658767 [TBL] [Abstract][Full Text] [Related]
38. Malaria, blood glucose, and the role of tumour necrosis factor (TNF) in mice. Elased KM; Taverne J; Playfair JH Clin Exp Immunol; 1996 Sep; 105(3):443-9. PubMed ID: 8809132 [TBL] [Abstract][Full Text] [Related]